Mallinckrodt (MNK) Mentioned Cautiously at Citron Research
Get Alerts MNK Hot Sheet
Join SI Premium – FREE
(Updated - November 9, 2015 1:57 PM EST)
Mallinckrodt (NYSE: MNK) was mentioned cautiously at Citron Research. Citron said the stock has more downside than Valeant Pharma (NYSE: VRX).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Knorex discloses going concern note in annual report
- Sk Hynix To Pay 60% Of Employee Bonuses In Company Stock, Says Source - Reuters
- Nvidia makes minority investment in Cloverleaf Infrastructure
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Short Sales, Trader Talk, Trading HaltsRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share